GLP-3 R 30mg
Retatrutide
CAS: 2381089-83-2
Retatrutide (GLP-3 R 30mg) — the highest-value vial for extended tri-receptor GLP research. At $11.67/mg, it is the most cost-efficient format for multi-week retatrutide protocols. Same CAS 2381089-83-2 compound, >98% HPLC purity, lyophilized powder.
Specifications
For laboratory research use only. Not for human consumption.
Phase 2 Dose-Response Data (48 Weeks)
Mean % body weight reduction by weekly dose — Phase 2 RCT, NEJM 2023
338 participants · 48-week duration · Primary endpoint: % body weight change
Mechanism of Action
Full tri-receptor agonism across GLP-1R, GIPR, and GcgR — identical mechanism to the 15mg vial. The 30mg format supports longer uninterrupted research runs and reduces per-mg cost by ~8% versus the 15mg.
Research FAQ
Is the 30mg the same compound as the 15mg?
Yes. Identical compound (Retatrutide, CAS 2381089-83-2), identical purity. The 30mg offers better per-mg value at $11.67/mg vs $12.67/mg for the 15mg.
Who is the 30mg vial for?
Researchers running multi-week protocols who want to minimize per-mg cost and reduce the number of reconstitution events.
